survival rate mesothelioma
According to a study published in the Journal on May 6, National Cancer Institute (JNCI), scientists have recently developed a test that can accurately predict which patients with mesothelioma have the best chance for survival. The test is also useful to identify which patients would be the best candidates for surgery, another treatment option for mesothelioma cancer.
The test works by identifying the relationships of four genes in tissue samples of mesothelioma cancer patients and compared with tissue samples from patients who have survived mesothelioma cancer for an extended period of time. The test gene showed consistent and easily provide repeatable results at the research campus. Despite the different technical using different instruments in different laboratories, the test showed a high efficacy rate.
The test was devised by Dr. Raphael Bueno, the Deputy Chief of the Division of Thoracic Surgery and Program Director of the Thoracic Surgery Residency at Brigham and Women's Hospital in Boston, Massachusetts. Previously, Mr. predict the prognosis of the patient is an invasive process, according to Dr. Good, major surgery is required to adequately predict the outcome. In the interest of creating a more accessible, less invasive and accurate test reports, Dr. Good and his team seemed preexisting cancer tests. Specifically, the team looked at two genes based on methods test were used to predict recurrence of breast cancer. Although this technology has not been widely used due to the heavy logistics requirements, the inspiration of a sufficient incentive to assist Dr. Good and his team to develop what could be one of the greatest advances in the accurate diagnosis of mesothelioma in the past years.
The study announced in JNCI was to determine the accuracy of the test predicts the survival rate of patients. The researchers examined tissue samples of 120 patients with mesothelioma and their cases continued until 2007 or until death. Using the ratio test gene, the researchers divided the participants into two groups: one group good results, and a group of poor prognosis. On average, the poor performance group survived 9.5 months, the group survived 16.8 months a good result, almost double the survival rate.
Because this test is so revealing about the survival rates of patients, provides an opportunity for families and individuals to choose the best treatment option for mesothelioma cancer. Patients with positive results of genetic testing may be more likely related benefit from surgery while in the lower survival rate for the best available supportive care.
Mesothelioma is often a condition very debilitating, it may require large amounts of physical therapy and treatment options, and require thousands of dollars in medical costs. It is common for many patients to consider a mesothelioma lawsuit with an experienced personal injury attorney.
By contacting a lawyer mesothelioma, a patient who is on the rise your chances of receiving monetary funds as compensation for damages suffered due to mesothelioma cancer. In addition, a mesothelioma lawsuit also may result in the reimbursement of expensive medical bills as well as opening the door for patients to receive expensive medical care that may otherwise be pay or receive.
About the Author:
For more information on mesothelioma, visit http://mesothelioma.legalview.com for access to a wide variety or resources, including a mesothelioma attorney, a
mesothelioma lawsuit
, and a mesothelioma lawyer. LegalView also provides access to a construction accident lawyer as well.
Article Source: ArticlesBase.com – New Gene Test Provides Approximate Survival Rates for Mesothelioma Patients
Mesothelioma And Asbestos Cancer Lawyers
